(Received for publication February 2, 1996) In the previous paper,r) we described the synthesis and antibacterial activities of cephalosporins which possess both catechol moiety at the 7-position and pyrimidiniumthiomethyl, pyrimidinothiomethyl, or pyrimidiniummethyl group at the 3-position of cephem nucleus.
Those compounds exhibited excellent activities against
Gram-negative bacteria, but showed moderate activities against Gram-positive bacteria. They also showed poor activities against E. faecalis. When vinyl spacer was introduced in the C-3 position of cephem nucleus as in the case of E-1077,2) the bioactivity was good against Gram-positive strains and also showed stability against /Mactamases. As a part of our research program on newinjectable cephalosporins possessing improved activity against Gram-positive bacteria while maintaining potent antibacterial activities against Gram-negative strains including P. aeruginosa, we have synthesized a new series of cephalosporins with a 3-substituted pyrimidiniumyl-, pyrimidinylthio-, or pyrimidiniumylthio-l-(is)-propenyl group and 7-substituted catechol moiety (Fig. 1) . We report herein the synthesis of these compounds and their antibacterial activities. Chemistry
The compounds1~9 from oxime 10 and bromide ll were prepared as follows (Scheme 1). Coupling of oxime 10 and benzyl bromide ll in the presence of potassium carbonate and potassium iodide in 7V,7V-dimethylformamide (DMF) followed by treatment with catalytic amount of Pd(0) afforded the carboxylic acid 12. The acid 12 was added to the methylene chloride solution containing /?-methoxybenzyl-7-amino-3-chloromethyl-3-cephem-4-carboxylate (7-ACLE) and pyridine at -20°C, then phosphorous oxychloride (POC13) was added to the solution to afford the allyl chloride 13. After preparation ofWittig reagent by treatment of triphenylphosphine and sodium iodide to the chloride 13, ylid was made by using 1n sodium hydroxide. Reaction of the ylid with the chloroacetaldehyde afforded (Z)-propenyl chloride 14. S.a., Staphylococcus aureus ATCC-6538p; E.f., Enterococcusfaecalis 292 12; E.c. l , Escherichia coli ATCC-10536; Ex.2, Escherichia coli TEM11 193E; P.a., Pseudomonas aeruginosa 1912E; Ax., Acinetobacter calcoaceticus 15473; Ex., Enterobacter cloacae P99; K.a., Klebsiella aerogenes SHV-1 1976E; S.m., Serratia marcescens 1826E. were shown in Table 2 . In rats, they showed significantly higher AUCvalues and longer half life compared to ceftazidime after a dose of 20 mg/kg intravenously.
